Singular Genomics Systems, Inc. (OMIC)
- Previous Close
0.4000 - Open
0.4000 - Bid --
- Ask --
- Day's Range
0.4000 - 0.4280 - 52 Week Range
0.3100 - 1.2100 - Volume
77,805 - Avg. Volume
116,206 - Market Cap (intraday)
30.694M - Beta (5Y Monthly) 1.40
- PE Ratio (TTM)
-- - EPS (TTM)
-1.3000 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.85
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
www.singulargenomics.comRecent News: OMIC
Performance Overview: OMIC
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OMIC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OMIC
Valuation Measures
Market Cap
29.63M
Enterprise Value
-69.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.00
Price/Book (mrq)
0.17
Enterprise Value/Revenue
-23.71
Enterprise Value/EBITDA
0.80
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-21.25%
Return on Equity (ttm)
-43.17%
Revenue (ttm)
2.91M
Net Income Avi to Common (ttm)
-94.82M
Diluted EPS (ttm)
-1.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
175.4M
Total Debt/Equity (mrq)
42.06%
Levered Free Cash Flow (ttm)
-36.81M